Every once in a while, medical researchers simply have a stroke of good luck. In this case, that “stroke of good luck” could have a profound effect on the medial community.
Researchers at Cardiff University that were in the midst of analyzing blood from a bank accidentally stumbled into an “entirely new type of T-cell”, according to The Daily Wire. The new cell carries a “never before seen” type of receptor that acts like a grappling hook, latching on to most human cancers.
Prior therapies, called CAR-T and TCR-T, which use immune cells to attach to HLA molecules on cancer cells’ surface, are incapable of fighting solid tumors, the article notes. HLA molecules vary in people, but the new therapy instead attaches to a molecule called MR1, which does not vary in humans. This gives the therapy a chance of fighting most cancers.